Skip to content
The Nexus
DossierENTITY

personalized tumor vaccines

Coverage of personalized tumor vaccines in the Nexus archive.

Earliest in view: Jun 29 · 03:00 UTCMost recent: Jun 29 · 03:00 UTC
Co-mentioned in this coverage
Chinaplace1Likang Life Sciencesorganization1Beijing Economic and Technological Development Zoneplace1AI-powered cancer vaccine production linetopic1cancertopic1
Recent coverage
  • HEALTHJun 29 · 03:00 UTCSCMP CHINA
    China’s first AI-powered cancer vaccine production line set to launch in Beijing

    China is developing its first AI-assisted personalized tumor vaccine production line, with Beijing-based Likang Life Sciences set to complete a drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October. The project, backed by a 110 million yuan investment, aims to address cancer, the nation's second-leading cause of death.